Three things to know:
1. Stryker’s portfolio comprises orthopedics and biologics-focused products developed by Wright Medical, which it acquired in a $4 billion deal in November.
2. A total ankle replacement device, preoperative navigation system, bone graft and deformity correction system are among the products that Stryker will bring to the event.
3. The company will also debut its Allofiber demineralized bone fibers, which are designed to promote bone growth for foot and ankle joint fusion surgeries.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
